These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35544108)

  • 1. Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study.
    Diallo MSK; Ayouba A; Keita AK; Thaurignac G; Sow MS; Kpamou C; Barry TA; Msellati P; Etard JF; Peeters M; Ecochard R; Delaporte E; Toure A;
    Lancet Microbe; 2021 Dec; 2(12):e676-e684. PubMed ID: 35544108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study.
    Diallo MSK; Rabilloud M; Ayouba A; Touré A; Thaurignac G; Keita AK; Butel C; Kpamou C; Barry TA; Sall MD; Camara I; Leroy S; Msellati P; Ecochard R; Peeters M; Sow MS; Delaporte E; Etard JF;
    Lancet Infect Dis; 2019 Mar; 19(3):308-316. PubMed ID: 30765243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study.
    Nkuba-Ndaye A; Dilu-Keti A; Tovar-Sanchez T; Diallo MSK; Mukadi-Bamuleka D; Kitenge R; Formenty P; Legand A; Edidi-Atani F; Thaurignac G; Pelloquin R; Mbala-Kingebeni P; Toure A; Ayouba A; Muyembe-Tamfum JJ; Delaporte E; Peeters M; Ahuka-Mundeke S;
    Lancet Infect Dis; 2024 Mar; 24(3):266-274. PubMed ID: 38043556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.
    Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M
    J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study.
    Etard JF; Sow MS; Leroy S; Touré A; Taverne B; Keita AK; Msellati P; Magassouba N; Baize S; Raoul H; Izard S; Kpamou C; March L; Savane I; Barry M; Delaporte E;
    Lancet Infect Dis; 2017 May; 17(5):545-552. PubMed ID: 28094208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.
    Bramble MS; Hoff N; Gilchuk P; Mukadi P; Lu K; Doshi RH; Steffen I; Nicholson BP; Lipson A; Vashist N; Sinai C; Spencer D; Olinger G; Wemakoy EO; Illunga BK; Pettitt J; Logue J; Marchand J; Varughese J; Bennett RS; Jahrling P; Cavet G; Serafini T; Ollmann Saphire E; Vilain E; Muyembe-Tamfum JJ; Hensely LE; Simmons G; Crowe JE; Rimoin AW
    J Infect Dis; 2018 Nov; 218(12):1929-1936. PubMed ID: 30107445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
    Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.
    Becquart P; Mahlakõiv T; Nkoghe D; Leroy EM
    PLoS One; 2014; 9(6):e96360. PubMed ID: 24914933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: A cohort study of frequency, duration, and risk factors.
    Thorson AE; Deen GF; Bernstein KT; Liu WJ; Yamba F; Habib N; Sesay FR; Gaillard P; Massaquoi TA; McDonald SLR; Zhang Y; Durski KN; Singaravelu S; Ervin E; Liu H; Coursier A; Marrinan JE; Ariyarajah A; Carino M; Formenty P; Ströher U; Lamunu M; Wu G; Sahr F; Xu W; Knust B; Broutet N;
    PLoS Med; 2021 Feb; 18(2):e1003273. PubMed ID: 33566817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea.
    Fischer K; Camara A; Troupin C; Fehling SK; Strecker T; Groschup MH; Tordo N; Diederich S
    Transbound Emerg Dis; 2020 Mar; 67(2):724-732. PubMed ID: 31627257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Ebola Virus Disease Survivor Blood and Semen in Liberia: Serology and Reverse Transcription Polymerase Chain Reaction (RT-PCR).
    Kofman A; Linderman S; Su K; Purpura LJ; Ervin E; Brown S; Morales-Betoulle M; Graziano J; Cannon DL; Klena JD; Desamu-Thorpe R; Fankhauser J; Orone R; Moses S; Glaybo U; Massaquoi M; Nyenswah T; Nichol ST; Kollie J; Kiawu A; Freeman E; Giah G; Tony H; Faikai M; Jawara M; Kamara K; Kamara S; Flowers B; Mohammed K; Chiriboga D; Williams DE; Hinrichs SH; Ahmed R; Vonhm B; Rollin PE; Choi MJ
    Clin Infect Dis; 2021 Dec; 73(11):e3641-e3646. PubMed ID: 32894277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma.
    Gilchuk P; Guthals A; Bonissone SR; Shaw JB; Ilinykh PA; Huang K; Bombardi RG; Liang J; Grinyo A; Davidson E; Chen EC; Gunn BM; Alter G; Saphire EO; Doranz BJ; Bukreyev A; Zeitlin L; Castellana N; Crowe JE
    Front Immunol; 2021; 12():706757. PubMed ID: 34335620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies.
    Ravichandran S; Khurana S
    EBioMedicine; 2022 Aug; 82():104186. PubMed ID: 35901660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
    Yu DS; Weng TH; Shen L; Wu XX; Hu CY; Wang FXC; Wu ZG; Wu HB; Wu NP; Li LJ; Yao H
    Cell Physiol Biochem; 2018; 50(3):1055-1067. PubMed ID: 30355918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.
    Sissoko D; Duraffour S; Kerber R; Kolie JS; Beavogui AH; Camara AM; Colin G; Rieger T; Oestereich L; Pályi B; Wurr S; Guedj J; Nguyen THT; Eggo RM; Watson CH; Edmunds WJ; Bore JA; Koundouno FR; Cabeza-Cabrerizo M; Carter LL; Kafetzopoulou LE; Kuisma E; Michel J; Patrono LV; Rickett NY; Singethan K; Rudolf M; Lander A; Pallasch E; Bockholt S; Rodríguez E; Di Caro A; Wölfel R; Gabriel M; Gurry C; Formenty P; Keïta S; Malvy D; Carroll MW; Anglaret X; Günther S
    Lancet Glob Health; 2017 Jan; 5(1):e80-e88. PubMed ID: 27955791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.
    Gilchuk P; Kuzmina N; Ilinykh PA; Huang K; Gunn BM; Bryan A; Davidson E; Doranz BJ; Turner HL; Fusco ML; Bramble MS; Hoff NA; Binshtein E; Kose N; Flyak AI; Flinko R; Orlandi C; Carnahan R; Parrish EH; Sevy AM; Bombardi RG; Singh PK; Mukadi P; Muyembe-Tamfum JJ; Ohi MD; Saphire EO; Lewis GK; Alter G; Ward AB; Rimoin AW; Bukreyev A; Crowe JE
    Immunity; 2018 Aug; 49(2):363-374.e10. PubMed ID: 30029854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines.
    Felgner J; Clarke E; Hernandez-Davies JE; Jan S; Wirchnianski AS; Jain A; Nakajima R; Jasinskas A; Strahsburger E; Chandran K; Bradfute S; Davies DH
    Antiviral Res; 2024 May; 225():105851. PubMed ID: 38458540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors.
    Sobarzo A; Stonier SW; Radinsky O; Gelkop S; Kuehne AI; Edri A; Herbert AS; Fedida-Metula S; Lutwama JJ; Yavelsky V; Davis C; Porgador A; Dye JM; Lobel L
    EBioMedicine; 2019 Aug; 46():215-226. PubMed ID: 31326432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.